Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Mondelez (MDLZ) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Jason English believing industry-wide cost pressures compounded with risk of weaker volumes and higher promotions is likely to weigh on the food group later this year. 2. Pinterest (PINS) downgraded to Neutral from Overweight at JPMorgan and downgraded to In Line from Outperform at Evercore ISI. 3. Agios Pharmaceuticals (AGIO) downgraded to Sell from Neutral at Goldman Sachs with analyst Salveen Richter saying the company's late-stage clinical pipeline is centered on a single asset, mitapivat, that is awaiting approval in the lead indication of pyruvate kinase deficiency. 4. Proofpoint (PFPT) downgraded to Market Perform from Outperform at JMP Securities with analyst Erik Suppiger saying the company is suspending guidance for the remainder of the year in light of the pending Thoma Bravo transaction set to close in Q3. 5. Orion Group (ORN) downgraded to Neutral from Buy at B. Riley with analyst Alex Rygiel saying the company's Q2 results were below expectations mostly due to weather impacts within its concrete segment. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.